抗炎性细胞因子与抑郁症
Anti-inflammatory Cytokines and Depression
查看参考文献98篇
文摘
|
细胞因子假说是关于抑郁症发病机理的重要假说,为探讨抑郁症的发病机理和临床治疗方法提供了新方向.细胞因子分为前炎性细胞因子和抗炎性细胞因子.前炎性细胞因子与抑郁症的发病密切相关,而抗炎性细胞因子可能具有抗抑郁的作用.本文着重综述抗炎性细胞因子与抑郁症的关系.抗炎性细胞因子如白介素10、白介素1受体拮抗剂、白介素4、白介素13、转化生长因子β和脂联素等,在抑郁症中表达下降;补充外源抗炎性细胞因子则具有一定的抗抑郁作用.抗炎性细胞因子可通过拮抗前炎性细胞因子的作用,并与MAPK信号通路、神经递质和糖皮质激素相互作用而参与到抑郁症中.抗抑郁药能使抗炎性细胞因子的表达上升,这可能是药物起效的机制之一.抗炎策略在抑郁症的治疗中有重要应用前景. |
其他语种文摘
|
In recent years, the cytokine hypothesis of depression has received considerable research attention, providing insights on the mechanism study and the therapeutic treatment of depressive disorders. Two classes of cytokines, pro-inflammatory cytokines and anti-inflammatory cytokines, are proven to be associated with depression. In this review, the focus is on the research of anti-inflammatory cytokines, which are believed to have a key role in alleviating depression-related symptoms. Anti-inflammatory cytokines, such as interleukin-10, interleukin-1 receptor antagonist, interleukin-4, interleukin-13, transforming growth factor-β, and adiponectin, show decreased concentrations during depressive episodes. Anti-inflammatory cytokines participate in the regulation mechanism of depression through antagonizing pro-inflammatory cytokines and interacting with MAPK signaling, neurotransmitters, and glucocorticoids. Various kinds of antidepressants can lead to an increased secretion of anti-inflammatory cytokines, which might be the action mechanism of antidepressants. Overall, accumulating evidences from the literature demonstrate positive prospects of using anti-inflammatory cytokines as a therapeutic alternative to treat depression. |
来源
|
生物化学与生物物理进展
,2014,41(11):1099-1108 【核心库】
|
DOI
|
10.3724/sp.j.1206.2013.00477
|
关键词
|
抑郁症
;
细胞因子
;
抗炎性细胞因子
;
抗炎作用
;
抗抑郁药
|
地址
|
中国科学院心理研究所, 中国科学院心理健康重点实验室, 北京, 100101
|
语种
|
中文 |
文献类型
|
综述型 |
ISSN
|
1000-3282 |
学科
|
社会科学总论;基础医学 |
基金
|
国家自然科学基金
;
中国科学院知识创新工程项目
|
文献收藏号
|
CSCD:5293119
|
参考文献 共
98
共5页
|
1.
Mathers C D. Projections of global mortality and burden of disease from 2002 to 2030.
PLoS Medicine,2006,3(11):e442
|
被引
237
次
|
|
|
|
2.
林文娟. 抑郁症的心理神经免疫学研究:细胞因子的作用.
心理科学进展,2008,16(3):404-410
|
被引
17
次
|
|
|
|
3.
Maes M. Evidence for an immune response in major depression:a review and hypothesis.
Prog Neuro-Psychopharmacol Biol Psychiat,1995,19(1):11-38
|
被引
27
次
|
|
|
|
4.
Lichtblau N. Cytokines as biomarkers in depressive disorder:current standing and prospects.
Int Rev Psychiat,2013,25(5):592-603
|
被引
12
次
|
|
|
|
5.
Patel A. Review:the role of inflammation in depression.
Psychiatria Danubina,2013,25(2):216-223
|
被引
4
次
|
|
|
|
6.
Moussavi S. Depression, chronic diseases, and decrements in health:results from the World Health Surveys.
The Lancet,2007,370(9590):851-858
|
被引
47
次
|
|
|
|
7.
Lang U E. Molecular mechanisms of depression:perspectives on new treatment strategies.
Cell Physiol Biochem,2013,31(6):761-777
|
被引
13
次
|
|
|
|
8.
Mesquita A R. IL-10 modulates depressive-like behavior.
J Psychiat Res,2008,43(2):89-97
|
被引
4
次
|
|
|
|
9.
Pan Y. The effects of central pro-and anti-inflammatory immune challenges on depressive-like behavior induced by chronic forced swim stress in rats.
Behavi Brain Res,2013,247:232-240
|
被引
7
次
|
|
|
|
10.
Strle K. lnterleukin-10 in the brain.
Critical Reviews~(TM) in Immunology,2001,21(5):427-449
|
被引
12
次
|
|
|
|
11.
Van Strien M E. Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages.
Gene Therapy,2010,17(5):662-671
|
被引
1
次
|
|
|
|
12.
Song C. Imbalance between pro-and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients:the effect of electroacupuncture or fluoxetine treatment.
Pharmacopsychiatry,2009,42(5):182-188
|
被引
10
次
|
|
|
|
13.
Dhabhar F S. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression.
J Psychiat Res,2009,43(11):962-969
|
被引
6
次
|
|
|
|
14.
Gao J. Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome.
Experimental and Therapeutic Medicine,2013,6(1):93-96
|
被引
6
次
|
|
|
|
15.
Holtzman S. A genetic predisposition to produce low levels of IL-10 is related to depressive symptoms:a pilot study of patients with end stage renal disease.
Psychosomatics,2012,53(2):155-161
|
被引
1
次
|
|
|
|
16.
Maes M. Negative immunoregulatory effects of antidepressants:inhibition of interferon-γ and stimulation of interleukin-10 secretion.
Neuropsychopharmacology,1999,20(4):370-379
|
被引
2
次
|
|
|
|
17.
Kubera M. Anti-inflammatory effects of antidepressants through suppression of the interferon-[gamma]/ interleukin-10 production ratio.
J Clin Psychopharm,2001,21(2):199-206
|
被引
3
次
|
|
|
|
18.
Szuster-Ciesielska A. In vitro immunoregulatory effects of antidepressants in healthy volunteers.
Polish J Pharma,2003,55(3):353-362
|
被引
1
次
|
|
|
|
19.
Kubera M. A new animal model of(chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4months.
Brain, Behavior, and Immunity,2013,31:96-104
|
被引
7
次
|
|
|
|
20.
Dantzer R. From inflammation to sickness and depression:when the immune system subjugates the brain.
Nat Rev Neurosci,2008,9(1):46-56
|
被引
97
次
|
|
|
|
|